MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2007; DOI: 10.1124/mol.107.040733


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.040733v1
73/2/369    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E


Received for publication August 8, 2007.
Revised November 7, 2007.
Accepted for publication November 7, 2007.

The {beta}1 subunit of L-type voltage-gated Ca2+ channels independently binds to and inhibits the gating of large-conductance Ca2+-activated K+ channels

Shengwei Zou 1, Smita Jha 1, Eun Young Kim 1, Stuart E Dryer 1*

1 University of Houston

* Address correspondence to: E-mail: sdryer{at}uh.edu

Abstract

Large conductance Ca2+- activated K+ channels (BKCa channels) encoded by the Slo1 gene are ubiquitously expressed, and play a role in regulation of many cell types. In excitable cells, BKCa channels and voltage-activated Ca2+ channels often form functional complexes that allow the cytoplasmic domains of BKCa channels to lie within spatially discrete calcium microdomains. Here we report a novel protein interaction between the {beta}1-subunit of L-type voltage-activated calcium channels (Cav{beta}1) and critical regulatory domains of Slo1 that can occur in the absence of other proteins. This interaction was identified by a yeast two-hybrid screen, and confirmed by confocal microscopy in native neurons, co-immunoprecipitation, and by direct binding assays. The Cav{beta}1 subunit binds within the calcium bowl domain of Slo1 that mediates a portion of high-affinity Ca2+-binding to BKCa channels, and also to a non-canonical Src Homology 3 (SH3) domain-binding motif within Slo1. Binding of Cav{beta}1 markedly slows Slo1 activation kinetics and causes a significant decrease in Ca2+ sensitivity in inside-out and in dialyzed cells, even in the absence of pore-forming subunits of Cav channels. The guanylate kinase (GK) domain of Cav{beta}1 mediates Slo1 regulation through its binding to calcium bowl domains, and this domain of Cav{beta}1 is necessary and sufficient for the observed effects on BKCa activation. Binding of Cav{beta}1 to SH3-binding motifs may stabilize the interaction with Slo1, or contribute to formation of other complexes, but does not appear to affect Ca2+-dependent gating of Slo1. Binding of Cav{beta}1 does not affect cell surface expression of Slo1 in HEK293T cells.


Key words: Ion channel regulation, Func. analysis receptor/ion channel mutants, Immunocytochemistry, Single channel kinetics, Yeast 2-hybrid


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Gonzalez-Gutierrez, E. Miranda-Laferte, D. Nothmann, S. Schmidt, A. Neely, and P. Hidalgo
The guanylate kinase domain of the {beta}-subunit of voltage-gated calcium channels suffices to modulate gating
PNAS, September 16, 2008; 105(37): 14198 - 14203.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics